Outset Medical Free Cash Flow 2019-2025 | OM

Outset Medical free cash flow from 2019 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Outset Medical Annual Free Cash Flow
2024 -117.22
2023 -134.81
2022 -154.05
2021 -133.37
2020 -108.09
2019 -73.59
2018 -48.21
Outset Medical Quarterly Free Cash Flow
2025-03-31 -25.79
2024-12-31 -117.22
2024-09-30 -100.68
2024-06-30 -79.72
2024-03-31 -46.27
2023-12-31 -134.81
2023-09-30 -109.32
2023-06-30 -74.54
2023-03-31 -45.57
2022-12-31 -154.05
2022-09-30 -117.44
2022-06-30 -80.39
2022-03-31 -39.81
2021-12-31 -133.37
2021-09-30 -99.85
2021-06-30 -71.22
2021-03-31 -39.54
2020-12-31 -108.09
2020-09-30 -79.62
2020-06-30 -49.05
2020-03-31 -27.69
2019-12-31
2019-09-30 -57.86
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.309B $0.114B
Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.130B 58.69
Doximity (DOCS) United States $11.290B 52.27
Hims & Hers Health (HIMS) United States $11.277B 117.16
Tempus AI (TEM) United States $10.557B 0.00
IRhythm Technologies (IRTC) United States $4.350B 0.00
Inspire Medical Systems (INSP) United States $3.741B 58.45
Hinge Health (HNGE) United States $3.664B 0.00
Privia Health (PRVA) United States $2.391B 163.42
Schrodinger (SDGR) United States $1.574B 0.00
Phreesia (PHR) United States $1.516B 0.00
Enovis (ENOV) United States $1.502B 8.37
Clover Health Investments (CLOV) United States $1.496B 0.00
10x Genomics (TXG) United States $1.496B 0.00
Azenta (AZTA) United States $1.427B 66.30
Omnicell (OMCL) United States $1.259B 22.22
Evolent Health (EVH) United States $1.119B 95.30
Claritev (CTEV) United States $0.702B 0.00
Fulgent Genetics (FLGT) United States $0.541B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.467B 0.00
Butterfly Network (BFLY) United States $0.462B 0.00
Talkspace (TALK) United States $0.415B 124.00
TruBridge (TBRG) United States $0.336B 746.33
Nyxoah SA (NYXH) Belgium $0.280B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
CapsoVision (CV) United States $0.211B 0.00
Zepp Health (ZEPP) Netherlands $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.155B 0.00
Pulmonx (LUNG) United States $0.127B 0.00
American Well (AMWL) United States $0.126B 0.00
EUDA Health Holdings (EUDA) Singapore $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.114B 0.00
CareCloud (CCLD) United States $0.101B 3.85
Insight Molecular Diagnostics (IMDX) United States $0.082B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.079B 0.00
111 (YI) China $0.066B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00